Replies to Post #282 onRelmada Therapeutics Inc. (RLMD)

Replies to post #282 on Relmada Therapeutics Inc. (RLMD)

Replies to #282 on Relmada Therapeutics Inc. (RLMD)

10/17/19 6:51 AM

#286 RE: biopicker #282

Tell that to VTGN. They’d love a $250M valuation. Ketamine based drugs don’t work. Ask JNJ after their failed program

10/17/19 6:53 AM

#287 RE: biopicker #282

How are 2.4M shares for sale with a $6 cost basis irrelevant? Lol